| 发明名称 |
Methods for treating cancer with a recombinant MVA expressing HER-2 |
| 摘要 |
The invention relates to compositions, kits, and methods for cancer therapy using recombinant MVA viruses encoding a tumor-associated antigen, such as HER-2, particularly in combination with taxanes. The taxanes can be administered prior to, at the same time as, or after the recombinant MVA virus.
|
| 申请公布号 |
US8313740(B2) |
申请公布日期 |
2012.11.20 |
| 申请号 |
US20100872156 |
申请日期 |
2010.08.31 |
| 申请人 |
DELCAYRE ALAIN;LAUS REINER;MANDL STEFANIE;BN IMMUNOTHERAPEUTICS, INC. |
发明人 |
DELCAYRE ALAIN;LAUS REINER;MANDL STEFANIE |
| 分类号 |
A61K31/70;A01N43/04;A61K48/00 |
主分类号 |
A61K31/70 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
